Form 8-K - Current report:
SEC Accession No. 0001104659-25-001666
Filing Date
2025-01-07
Accepted
2025-01-07 16:05:27
Documents
14
Period of Report
2025-01-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm252102d1_8k.htm   iXBRL 8-K 27038
2 EXHIBIT 99.1 tm252102d1_ex99-1.htm EX-99.1 18224
  Complete submission text file 0001104659-25-001666.txt   224586

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20250107.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20250107_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20250107_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT tm252102d1_8k_htm.xml XML 3679
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39683 | Film No.: 25514894
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)